Royal Society of Chemistry, Dalton Transactions, 27(50), p. 9500-9511, 2021
DOI: 10.1039/d1dt01388b
Full text: Unavailable
A new family of cationic ruthenium(ii) metallodendrimers of a carbosilane nature with the metal centre coordinated to 2-aminopyridine ligands have been synthesized and interacted with conventional anticancer drugs.